| Spirig HealthCare AG - Olmesartan Amlo Spirig HC 40mg/5mg, Filmtabletten | | 66520 | | 02 | | Olmesartan Amlo Spirig HC 40mg/5mg | | Filmtabletten | | C09DB02 | | Olmesartan Medoxomil und Amlodipin | | 11.01.2018 | | |
| | Composition | | Filmtablette: olmesartanum medoxomilum 40 mg, amlodipinum 5 mg ut amlodipini besilas, cellulosum microcristallinum, crospovidonum Typ A, silica colloidalis anhydrica, magnesii stearas, lactosum monohydricum 66.845 mg, Überzug: hypromellosum, lactosum monohydricum 2.52 mg, macrogolum 3350, E 171, E 172 (flavum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. | informations additionels |
|---|
| Amlodipine | 5 mg | | | Olmesartanum Medoxomilum | 40 mg | Filmtablette |
| | BAG: Principe actif | Concentr. |
|---|
| Amlodipine | 5 mg | | Olmesartan Medoxomil | 40 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum typ A | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 2.52 mg | | | Macrogol | 3350 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
